Eckart Meese began his scientific career in biology and theology before completing his diploma in genetics and a PhD in human genetics. After his post doc in molecular biology on human melanoma at the Arizona Cancer Center, USA he worked on gene mapping in radiation oncology at the University of Michigan, USA. Meese later joined the medical faculty of Saarland University, Germany, as professor of human genetics. His current research focus is on the genetic changes of human solid tumors, autoantibody expression patterns and the development of blood born miRNA signatures for human diseases.
Andreas Keller completed his doctoral studies in computational biology at the Center for Bioinformatics at Saarland University, Germany in 2009. After finishing the PhD thesis Keller joined the Heidelberg based biotech company Febit as Vice President of biomarker discovery. In his new role he was responsible for the miRNA based biomarker program as well as for the bioinformatics department. In 2011, he became Director Technology Innovation at Siemens Healthcare in Erlangen, Germany. His focus of the work at Siemens was in in vitro diagnostics, specifically genomics approaches based on next generation sequencing as well as healthcare IT. In 2013, Keller became professor for clinical bioinformatics at Saarland University. In his new role he aims to foster a closer interaction between computational biology and clinical care.